Finance

Beta
Ask
Lists
603976:SHA
Chongqing Zhengchuan Pharmac Pckg Co Ltd
CNÂĄ25.56
-7.73%
(-2.14) 1D
Jun 18, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603976...
Open
CNÂĄ27.70
High
CNÂĄ28.00
Low
CNÂĄ24.95
Mkt. cap
3.81B
Avg. vol.
5.31M
Volume
12.92M
Dividend
1.13%
Quarterly dividend
CNÂĄ0.07
Ex-dividend date
May 28, 2026
P/E ratio
241.34
52-wk high
CNÂĄ28.03
52-wk low
CNÂĄ16.81
EPS
CNÂĄ0.11
Shares outstanding
151.20M
No. of employees
1K
Open
CNÂĄ27.70
High
CNÂĄ28.00
Low
CNÂĄ24.95
Mkt. cap
3.81B
Avg. vol.
5.31M
Volume
12.92M
Dividend
1.13%
Quarterly dividend
CNÂĄ0.07
Ex-dividend date
May 28, 2026
P/E ratio
241.34
52-wk high
CNÂĄ28.03
52-wk low
CNÂĄ16.81
EPS
CNÂĄ0.11
Shares outstanding
151.20M
No. of employees
1K
News stories
From sources across the web
About Chongqing Zhengchuan Pharmac Pckg Co Ltd
CEO-
Employees1.36K
Founded1988
Headquarters-
SectorMedical device
Websitecqzcjt.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
162.10M
134.08M
206.62M
208.63M
Cost of goods sold
138.37M
108.19M
183.21M
170.59M
Cost of revenue
138.37M
108.19M
183.21M
170.59M
Research and development expenses
2.00M
3.96M
4.96M
2.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.35M
12.04M
16.42M
13.24M
Operating expense
23.23M
11.16M
30.31M
23.58M
Total operating expenses
161.61M
119.35M
213.52M
194.18M
Operating income
487.40K
14.73M
-6.90M
14.45M
Other non operating income
50.91K
321.66K
-469.98K
686.35K
EBT including unusual items
3.38M
1.55M
3.01M
7.25M
EBT excluding unusual items
-1.71M
10.93M
-9.96M
11.00M
Income tax expense
208.28K
-704.36K
447.43K
422.05K
Effective tax rate
6.16%
-45.54%
14.86%
5.82%
Other operating expenses
4.49M
-3.49M
8.03M
3.47M
Net income
3.17M
2.25M
2.56M
6.83M
Net profit margin
1.96%
1.68%
1.24%
3.27%
Earnings per share
-
-
-
-
Interest and investment income
2.82M
1.51M
2.52M
1.24M
Interest expense
-5.32M
-5.38M
-5.39M
-5.38M
Net interest expenses
-2.51M
-3.87M
-2.87M
-4.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
27.83M
43.32M
19.70M
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer